We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1378:HKEXChina Hongqiao Group Limited Analysis

Data as of 2026-03-13 - not real-time

HK$39.52

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

China Hongqiao (1378.HK) is trading at HK$39.52, just below its DCF-derived fair value of roughly HK$40.08, implying a modest upside of about 3%. The stock sits comfortably above its 20‑day SMA (HK$37.42) and 50‑day SMA (HK$36.31), and well above the long‑term 200‑day SMA (HK$27.31), underscoring a clear bullish trend. Technical momentum is supportive, with an RSI of 58.6, a bullish MACD histogram, and an increasing volume trend, while the market sentiment index reads “Greed” at 72.73. Fundamentally, the company delivers strong profitability—ROE of 24.8% and operating margin of 22.2%—and generates robust cash flow (operating cash flow ≈ HK$42.0 bn). The dividend yield of 5.16% coupled with a payout ratio of 54.9% signals a sustainable income stream, and the balance sheet, though leveraged (debt‑to‑equity ~66%), is backed by ample cash reserves (≈ HK$48.7 bn).
Given the bullish technical setup, modest valuation upside, and solid fundamentals, the stock presents a compelling case for investors seeking a blend of growth and value attributes. The sector’s cyclicality and regulatory environment in China introduce medium‑level risks, but the company’s diversified operations across multiple regions and its strong liquidity mitigate these concerns. Overall, the upside potential, attractive yield, and resilient earnings profile make China Hongqiao a favorable addition to a balanced portfolio.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (RSI, MACD, price above key SMAs)
  • Modest valuation upside (~3%) to DCF fair value
  • Increasing volume supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong cash generation and healthy operating margins
  • Sustainable dividend yield above 5% with reasonable payout ratio
  • Fundamental growth drivers such as 10% revenue growth and solid ROE

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term undervaluation relative to intrinsic value
  • Diversified global footprint reducing single‑country exposure
  • Resilient balance sheet with ample cash to service debt and fund expansion

Key Metrics & Analysis

Financial Health

Revenue Growth10.10%
Profit Margin15.63%
P/E Ratio12.8
ROE24.81%
ROA11.12%
Debt/Equity65.78
P/B Ratio2.9
Op. Cash FlowHK$42.0B
Free Cash FlowHK$20.4B

Technical Analysis

TrendBullish
RSI58.6
SupportHK$34.58
ResistanceHK$41.20
MA 20HK$37.42
MA 50HK$36.31
MA 200HK$27.31
MACDBullish
VolumeIncreasing
Fear & Greed Index72.73

Valuation

Fair ValueHK$40.08
Target PriceHK$40.70
Upside/Downside3.00%
GradeUndervalued
TypeBlend
Dividend Yield5.16%

Risk Assessment

Beta0.32
Volatility59.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.